ARM Innovation Hub
Advertisement: Cambridge Network mid banner
RealVNC mid banner careers
Advertisement: Howard Group mid banner
Advertisement: EY Mid banner
Advertisement: EBCam mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: Hewitsons mid banner
Advertisement – Charles Stanley mid banner
Barr Ellison Solicitors – commercial property
Advertisement: Simpsons Creative
Mid banner advertisement: BDO
Advertisement: RSM
Advertisement mid banner S-Tech 1
Advertisement: Mogrify mid banner
25 August, 2006 - 16:10 By Staff Reporter

Second Danish deal for Sareum Holdings

Sareum Holdings, a specialist structure-based drug discovery business, has entered into a second collaborative agreement with H. Lundbeck A/S (Copenhagen: LUN), an international pharmaceutical company with sales of around 1.2 billion Euros in 2005, to provide protein structure determination capabilities to accelerate drug discovery research at Lundbeck. Sareum will apply its skills in high throughput protein expression, purification and structure determination to help Lundbeck scientists develop new and improved therapeutics to assist patients suffering from diseases of the central nervous system – Lundbeck’s key drug discovery focus area.

In return, Sareum will receive research fees and success milestone payments.

Financial terms of the agreement have not been disclosed.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features